FRANCISCO JAVIER
GIL BEA
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (17)
2022
-
Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model
International Journal of Molecular Sciences, Vol. 23, Núm. 7
2021
-
Corticosteroid-binding-globulin (CBG)deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus
PLoS ONE, Vol. 16, Núm. 2 February
2018
-
Maternal imprinting on cognition markers of wild type and transgenic Alzheimer's disease model mice
Scientific Reports, Vol. 8, Núm. 1
2017
-
Aggregation of the inflammatory s100a8 precedes a? plaque formation in transgenic app mice: Positive feedback for s100a8 and a? productions
Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 72, Núm. 3, pp. 319-328
-
Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1863, Núm. 4, pp. 991-1001
2016
-
Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease
Hippocampus, Vol. 26, Núm. 10, pp. 1303-1312
2015
-
Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease
Aging Cell, Vol. 14, Núm. 1, pp. 122-129
-
Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease
Neuropathology and Applied Neurobiology, Vol. 41, Núm. 4, pp. 471-482
-
Resistance training does not have an effect on cognition or related serum biomarkers in nonagenarians: A randomized controlled trial
International Journal of Sports Medicine, Vol. 36, Núm. 1, pp. 54-60
2013
-
Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 6, pp. 837-847
-
Mineralocorticoid Receptor Activation Induces Insulin Resistance Through c-Jun N-terminal kinases in Response to Chronic Corticosterone: Cognitive Implications
Journal of Neuroendocrinology, Vol. 25, Núm. 4, pp. 350-356
2012
-
Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice
Neurobiology of Disease, Vol. 48, Núm. 3, pp. 439-446
2011
-
Cardiotrophin-1 is a key regulator of glucose and lipid metabolism
Cell Metabolism, Vol. 14, Núm. 2, pp. 242-253
-
Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF down regulation
Hippocampus, Vol. 21, Núm. 9, pp. 999-1009
2010
-
HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease
Journal of Alzheimer's Disease, Vol. 22, Núm. 3, pp. 829-838
2006
-
Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease
Neurobiology of Aging, Vol. 27, Núm. 8, pp. 1110-1117
2005
-
Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit
Neuroscience Letters, Vol. 375, Núm. 1, pp. 37-41